Long-term Follow-up Study of AL-001 Ophthalmic Injection in Subjects with WAMD

Clinical trial NCT06718816 · RECRUITING

Trial details

NCT number: NCT06718816
Sponsor: Beijing Anlong Biopharmaceutical Co., Ltd.
Status: RECRUITING
Study type: OBSERVATIONAL

Wet Age-related Macular Degeneration (wAMD)

Start date: 2024-12-09
Primary completion: 2029-06-30
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.